Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuracle has developed the NEO BCI system, a semi-invasive brain-computer interface device. In December 2024, the first successful implant surgery was performed at Huashan Hospital of Fudan University on a patient with severe spinal cord injury and hand paralysis. The patient showed significant functional improvement within one month post-surgery. The device enables wireless neural signal transmission to external devices, supporting rehabilitation and task performance. Large-scale clinical trials are planned for 2025, targeting up to 50 surgeries nationwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuracle Medical Technology.